快樂小藥師
目前分類:醫藥新聞 (608)
- Sep 19 Fri 2014 07:17
FDA Consumer Advice on Powdered Pure Caffeine
- Sep 09 Tue 2014 08:26
強冠「全統香豬油」下游廠商明細 0908更新
- Jun 19 Thu 2014 08:33
我對醫勞盟裡面的部分人士誤解醫療人員的意義深表遺憾
- Jan 13 Mon 2014 06:02
部分獸醫誤解醫藥分業合作的意義,揚言罷工
- Jan 11 Sat 2014 06:07
[轉載] AdhereTech推出智慧型藥瓶,能自動提醒病人按時按量用藥
- Jan 04 Sat 2014 08:38
[MedWatch]Onfi (clobazam): Drug Safety Communication - Risk of Serious Skin Reactions
ISSUE: FDA is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death. FDA approved changes to the Onfi drug label and the patient Medication Guide to describe the risk of these serious skin reactions.
- Nov 01 Fri 2013 07:58
[Medical News]FDA Label Changes Underline Risks With Ezogabine (Retigabine)
The US Food and Drug Administration (FDA) has announced approval of changes to labeling for the antiseizure medication ezogabine (Potiga, Valeant Pharmaceuticals International) to underline previously reported risks for retinal abnormalities, potential vision loss, and skin discoloration, all of which may become permanent.
- Aug 16 Fri 2013 00:45
[Medical News]FDA Strengthens Warning on Mefloquine Risks
The US Food and Drug Administration (FDA) is updating its warning about the antimalarial drug mefloquine hydrochloride to include the risk for neurologic as well as psychiatric adverse events, the agency announced today.
- Jul 27 Sat 2013 07:04
[Medical News]FDA, EMA Come Down Hard on Oral Ketoconazole FDA建議不要將口服ketoconazole作為第一線黴菌治療給藥
Clinicians should no longer prescribe ketoconazole (Nizoral, Janssen Pharmaceuticals) tablets as a first-line therapy for any fungal infection because of the risk for severe liver injury, adrenal insufficiency, and adverse drug interactions, the US Food and Drug Administration (FDA) announced today.
- Jul 18 Thu 2013 10:34
[Medscape][Medical News]Olmesartan Label to Include Intestinal Problems 雅脈仿單加註對腸胃的影響
The US Food and Drug Administration has approved a label change for the angiotensin-receptor blocker (ARB) olmesartan (Benicar, Daiichi Sankyo) to state that the drug can cause an intestinal problem known as spruelike enteropathy [1]].
- May 12 Sun 2013 09:53
[轉載]在醫院,不爽就打,絕對錯不了!
在醫院,不爽就打,絕對錯不了!
觀點‧誌 / 劉育志
小藥師本人非常反對這樣的暴力矯情行為,特在此處轉貼劉醫師的文章,希望呼籲大眾覺醒,不要拿醫療人員當做出氣筒。
近年來急診暴力不斷,加上醫療工作條件劣化,請大家善待醫療人員,謝謝。
- Mar 09 Sat 2013 20:41
荒謬的法案:18歲不能購醫療器材或藥品法案
- Jan 05 Sat 2013 05:51
上海地鐵站出現自動販賣機賣藥
- May 14 Mon 2012 05:18
[Science daily][Science News]Sunscreen Ingredient May Be Linked to Endometriosis 防曬成分可能增加女性罹患子宮內膜異位症風險
有些防曬乳、保養品含有「二苯酮」(Benzophenone-BP)成份,這種成份可幫助對抗紫外線。不過美國最新研究發現,「二苯酮」會模擬女性雌激素作用,很可能增加女性罹患子宮內膜異位症風險。
Scientists are reporting a possible link between the use of sunscreen containing a certain ingredient that mimics the effects of the female sex hormone estrogen and an increased risk of being diagnosed with endometriosis, a painful condition in which uterine tissue grows outside the uterus.
- May 13 Sun 2012 05:17
[Science daily][Science News]Sunscreen Ingredient May Increase Skin Cancer Risk 防曬劑的成分可能會增加皮膚癌的風險
研究顯示,粒子越小的氧化鋅(例如 microfine zinc oxide 或更小的 nano zinc oxide),越有可能被肌膚吸收,間接影響人體細胞,因此也越不安全。氧化鋅在陽光下,會釋出不穩定的游離基,後者和其他分子結合時會損害細胞。而且氧化鋅被陽光照射時間愈長,對人體細胞損害愈大。但研究員指出,上述理論仍屬初步研究階段,要作更多測試驗證。
As vacationers prepare to spend time outdoors this summer, many of them will pack plenty of sunscreen in hopes it will protect their bodies from overexposure, and possibly from skin cancer. But researchers at Missouri University of Science and Technology are discovering that sunscreen may not be so safe after all.
- May 07 Mon 2012 05:33
[轉載]醫改會電訪實錄
- May 05 Sat 2012 05:24
[ScienceDaily][Science News]NSAIDs and Cardiovascular Risk Explained
After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.
- May 03 Thu 2012 04:26
The Antibiotic, Amoxicillin-Clavulanate, Before a Meal May Improve Small Bowel Motility 飯前服用Augmentin可能可以刺激小腸蠕動
The common antibiotic, amoxicillin-clavulanate, may improve small bowel function in children experiencing motility disturbances, according to a study appearing in the June print edition of the Journal of Pediatric Gastroenterology and Nutrition from Nationwide Children's Hospital.
- Oct 12 Wed 2011 05:27
科學家:「鼻纖毛」可更精確測死亡時間
- Oct 08 Sat 2011 05:51
食品藥物管理管理局提醒使用topiramate 成分藥品應注意事項